drugset / Trial / NCT07613710

A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy

NCT07613710 ↗

Phase 1 Recruiting 104 enrolled H. Lundbeck A/S
RandomizedSequentialQuadruple-blindTreatment

Summary

The purpose of the trial is to determine if Lu AH69593 is safe and well tolerated. The trial will also look at how the body processes Lu AH69593 with and without food.

Timeline

Start
2025-06-13
Primary completion
2026-12-01
Completion
2026-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AH69593 Unknown — Oral

Indications